Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Farrell

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Nature Communications|January 22, 2021
Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeresTimothy P Lippert, Paulina Marzec, Aurora I Idilli, et al.
Nucleic Acids Research|February 18, 2016
RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growthAndrea Gunnell, Helen M Webb, C David Wood, et al.
Journal of Virology|January 21, 2011
Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell linesGoran Gregorovic, Rachel Bosshard, Claudio Elgueta Karstegl, et al.
Plos Pathogens|August 5, 2021
EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytesChenhe Su, Fang Lu, Samantha S Soldan, et al.
Cancer Research|April 4, 2002
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativityMilena Gasco, Alexandra K Bell, Victoria Heath, et al.
Blood|September 15, 2005
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignanciesNelofer Syed, Paul Smith, Alexandra Sullivan, et al.
Journal of Virology|May 19, 2017
Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNASamantha Correia, Anne Palser, Claudio Elgueta Karstegl, et al.
Journal of Virology|August 17, 2018
Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and DiseasesSamantha Correia, Ray Bridges, Fanny Wegner, et al.
Oncogene|February 22, 2002
Concomitant inactivation of p53 and Chk2 in breast cancerAlexandra Sullivan, Martin Yuille, Claire Repellin, et al.
British Journal of Haematology|August 25, 2021
Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBVCristina Venturini, Charlotte J Houldcroft, Arina Lazareva, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Nature Communications|January 22, 2021
Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeresTimothy P Lippert, Paulina Marzec, Aurora I Idilli, et al.
Nucleic Acids Research|February 18, 2016
RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growthAndrea Gunnell, Helen M Webb, C David Wood, et al.
Journal of Virology|January 21, 2011
Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell linesGoran Gregorovic, Rachel Bosshard, Claudio Elgueta Karstegl, et al.
Plos Pathogens|August 5, 2021
EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytesChenhe Su, Fang Lu, Samantha S Soldan, et al.
Cancer Research|April 4, 2002
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativityMilena Gasco, Alexandra K Bell, Victoria Heath, et al.
Blood|September 15, 2005
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignanciesNelofer Syed, Paul Smith, Alexandra Sullivan, et al.
Journal of Virology|May 19, 2017
Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNASamantha Correia, Anne Palser, Claudio Elgueta Karstegl, et al.
Journal of Virology|August 17, 2018
Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and DiseasesSamantha Correia, Ray Bridges, Fanny Wegner, et al.
Oncogene|February 22, 2002
Concomitant inactivation of p53 and Chk2 in breast cancerAlexandra Sullivan, Martin Yuille, Claire Repellin, et al.
British Journal of Haematology|August 25, 2021
Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBVCristina Venturini, Charlotte J Houldcroft, Arina Lazareva, et al.
Pageof 7